UK markets close in 7 hours 10 minutes
  • FTSE 100

    7,009.98
    +101.22 (+1.47%)
     
  • FTSE 250

    17,618.21
    +333.33 (+1.93%)
     
  • AIM

    816.23
    +7.50 (+0.93%)
     
  • GBP/EUR

    1.1528
    +0.0012 (+0.11%)
     
  • GBP/USD

    1.1387
    +0.0067 (+0.60%)
     
  • BTC-GBP

    17,624.43
    +694.09 (+4.10%)
     
  • CMC Crypto 200

    455.74
    +20.39 (+4.68%)
     
  • S&P 500

    3,678.43
    +92.81 (+2.59%)
     
  • DOW

    29,490.89
    +765.38 (+2.66%)
     
  • CRUDE OIL

    84.02
    +0.39 (+0.47%)
     
  • GOLD FUTURES

    1,717.50
    +15.50 (+0.91%)
     
  • NIKKEI 225

    26,992.21
    +776.42 (+2.96%)
     
  • HANG SENG

    17,079.51
    -143.32 (-0.83%)
     
  • DAX

    12,484.83
    +275.35 (+2.26%)
     
  • CAC 40

    5,952.15
    +158.00 (+2.73%)
     

Novavax's Revenue Could Fall Even More -- and It's Actually Good News

·4-min read

Pick your favorite of these adjectives, and it will definitely apply to Novavax's (NASDAQ: NVAX) second-quarter update. What's more, Novavax slashed its full-year revenue guidance. Unsurprisingly, Novavax stock crashed on the atrocious, bad, dismal, horrible news.